Skip to main navigation Skip to search Skip to main content

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study.

  • Paul G. Richardson
  • , David S. Siegel
  • , Ravi Vij
  • , Craig C. Hofmeister
  • , Rachid Baz
  • , Sundar Jagannath
  • , Christine Chen
  • , Sagar Lonial
  • , Andrzej Jakubowiak
  • , Nizar Bahlis
  • , Kevin Song
  • , Andrew Belch
  • , Noopur Raje
  • , Chaim Shustik
  • , Suzanne Lentzsch
  • , Martha Lacy
  • , Joseph Mikhael
  • , Jeffrey Matous
  • , David Vesole
  • , Min Chen
  • Mohamed H. Zaki, Christian Jacques, Zhinuan Yu, Kenneth C. Anderson
  • Harvard University
  • John Theurer Cancer Center, Hackensack, NJ;
  • Washington University in St. Louis
  • Ohio State University
  • H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL;
  • Mount Sinai Hospital
  • Princess Margaret Hospital, Toronto, ON, Canada;
  • Emory University
  • University of Chicago
  • University of Calgary
  • Vancouver General Hospital
  • University of Alberta
  • Royal Victoria Hospital, Montreal, QC, Canada;
  • Columbia University
  • Mayo Clinic
  • Colorado Blood Cancer Institute, Denver, CO; and
  • Celgene

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume123
Issue number12
DOIs
StatePublished - Mar 20 2014
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Surgery
  • Urology

Cite this